Michael J. Morris, MD

Michael J. Morris, MD, is the prostate cancer section head, Division of Solid Tumor Oncology, at Memorial Sloan Kettering Cancer Center in New York, NY. Dr Morris received his medical degree from Icahn School of Medicine at Mount Sinai. He completed his residency in medicine at Columbia Presbyterian Medical Center (currently known as Columbia University Irving Medical Center) and his fellowships in oncology and hematology at Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, respectively.

Dr Morris is a board-certified medical oncologist who specializes in the treatment of patients with prostate cancer, particularly those who have metastatic disease or are at high risk of developing metastatic disease. He has a specific research interest in the field of bone and tumor directed radiopharmaceuticals, and in developing novel imaging biomarkers for the disease.

He is the medical director of the Prostate Cancer Clinical Trials Consortium, an initiative designed to increase patient access to clinical trials in the United States. He chairs the Genitourinary Committee of the National Cancer Institute’s Alliance for Clinical Trials in Oncology, which facilitates the testing of new drugs nationwide.

Dr Morris was included in Castle Connolly’s Top Doctors: New York Metro Area in New York Magazine in 2013 and in 2015 through 2018.